KEGG Spider: Interpretation of Genomics Data in the Context of the Global Gene

Scientists from Helmholtz Zentrum München have developed a breakthrough methodology for understanding metabolism related variations from experimental genomics data. Using proposed bioinformatics strategy they were able to demonstrate that in most cases identified disease-specific metabolism variations are not independent, e.g. deregulated genes from different pathways are linked to each other via one or two step of consecutive metabolic reactions. The methodology may prompt new drug development strategies to affect/change metabolism of the disease cells.

The results of the German research team, which consists of scientists from Helmholtz Zentrum München (National German Research Center for Environmental Health) have been published on 18 December 2008, in the open access journal "Genome Biology".

In the post-genomic era the targets of many clinical experimental studies are complex cell disorders. A standard experimental strategy is to compare the genetic/proteomics signature of cells in normal and anomalous states. As a result, a set of genes with differential activity is delivered. In the next step, the interpretation of identified genes in a model context is required. A widely accepted strategy is to infer biological processes that are most relevant to the analyzed gene list. The inference is based on prior knowledge of individual gene properties, such as gene biological functions or interactions. This common approach is usually referred as enrichment analysis. The major limitation of such type of analyses is an ability to understand the connections between genes from different and seems to be unrelated pathways.

In comparison to previously developed methods, KEGG spider provides a robust analytical framework for interpretation of gene lists in the context of a global gene metabolic network. The information of gene pair wise relations is widely exploited (gene A is related to gene B via metabolite C) and the inferred network model is not limited to the size of one metabolic pathway.

Examples of analysis of disease-specific genes by KEGG spider suggest that the split of metabolic reactions to canonical pathways is to some degree artificial. In most cases, metabolism-related genes were from several KEGG canonical pathways. However, the analysis with KEGG spider reveals that, if to consider the topology of the global gene metabolic network, these genes form a non-interrupted (maximum one or two gene is missing) disease-specific pathway, which run through several canonical pathways. These results also support a hypothesis that disease-specific metabolism variations in most cases are not independent, e.g. deregulated genes from different pathways are linked to each other via one or two step consecutive metabolic reactions. Of about twenty examples of analysis of disease-specific genes presented in the paper may serve as support for this hypothesis.

Reference
Antonov A.V., Dietmann S., Mewes G.W. KEGG spider: interpretation of genomics data in the context of the global gene metabolic network. Genome Biology 2008, 9:R179 doi:10.1186/gb-2008-9-12-r179.

About the Institute of Bioinformatics and Systems Biology (Munich Information Center for Protein Sequences)
The Munich Information Center for Protein Sequences (MIPS-GSF, Neuherberg, Germany) provides genome-related information and analyses in a systematic way. Institute supports both national and European sequencing and functional analysis projects, develops and maintains automatically generated and manually annotated genome-specific databases, develops systematic classification schemes for the functional annotation of protein sequences, and provides tools for the comprehensive analysis experimental data. For further information, please visit http://mips.gsf.de/.

About Helmholtz Zentrum München
The Helmholtz Zentrum München is a research institution of the Federal Government and the State of Bavaria within the Helmholtz Association of German Research Centres, the largest scientific organisation in Germany.

The Helmholtz Association is a community of 15 scientific-technical and biological-medical research centres. These centres have been commissioned with pursuing long-term research goals on behalf of the state and society. The Association strives to gain insights and knowledge so that it can help to preserve and improve the foundations of human life. It does this by identifying and working on the grand challenges faced by society, science and industry. Helmholtz Centres perform top-class research in strategic programmes in six core fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter, Transport and Space.

In future, the Helmholtz Zentrum München will be represented within the research field Health of the Helmholtz Association with both programs, Environmental Health und Systemic Analysis of Multifactorial Diseases, as well as in the field Earth and Environment with the Terrestrial Environment program.

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...